IRCT138711201155N4已完成3 期
Comparison of Pegylated Interferon alfa-2a plus Adefovir and Pegylated Interferon alfa-2a alone in the treatment of chronic hepatitis B with genotype D (multicenter study)
Guilan University of Medical Sciences0 个研究点目标入组 74 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 74
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 65 years（—）
- 性别
- All
入选标准
- •Presence of hepatitis B for more than 6 month, ALT more than 1/1 normal upper limit and less than 10 ULN, 1810.000 copies/ml.
- •Exclusion criteria: Receiving anti neoplasm, anti viral or immunomedulator drugs during 6 months prior to study, previous treatment, coinfection with Hepatitis A,C,D viruses or HIV, Severe dysfunction of liver and kidney, pregnancy, breast feeding, refusing to give informed consent .
排除标准
- 未提供
研究者
相似试验
未知
3 期
A study of peginterferon alfa-2a in combination with ribavirin in patients with chronic Hepatitis C.Chronic hepatitis CJPRN-jRCT2080220023Chugai Pharmaceutical Co., Ltd.
未知
2 期
A study of peginterferon alfa-2a in combination with ribavirin in chronic hepatitis C(CHC) patients with compensated liver cirrhosis(LC).CHC with compensated LCJPRN-jRCT2080220215Chugai Pharmaceutical Co., Ltd.
招募中
3 期
Comparison of the effect of interferon alfa 2 b (IFN-a2b) drops with mitomycin c during surgery on pterygium recurrence in pterygium surgeryPterygium.Pterygium of eyeH11.0IRCT20160919029871N5Rasht University of Medical Sciences58
已完成
不适用
The effectiveness of peginterferon -alpha2a and the entecavir combination therapy for the chronic hepatitis B patientJPRN-UMIN000016275Kinki University School of Medicine50
已完成
不适用
A dose comparing study of peginterferon alfa-2b plus ribavirin in chronic hepatitis type C except genotype 1 and high pretreatment viremia.: A randomized open-label pilot study.JPRN-C000000313Hiroshima liver study group120